Henrik Bjursten
1 – 10 of 69
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis : The REPRISE III Randomized Clinical Trial
- Cyclosporine before Coronary Artery Bypass Grafting Does Not Prevent Postoperative Decreases in Renal Function : A Randomized Clinical Trial
- 2017
- Recombinant factor VIIa use in acute type A aortic dissection repair : A multicenter propensity-score-matched report from the Nordic Consortium for Acute Type A Aortic Dissection
- The safety of introducing a new generation TAVR device : One departments experience from introducing a second generation repositionable TAVR
- Predictors and impact of massive bleeding in acute type A aortic dissection
- 2016
- The predictive value of s-cystatin C for mortality after coronary artery bypass surgery
- Late survival and heart failure after transcatheter aortic valve implantation.
- Ciclosporin to Protect Renal function In Cardiac Surgery (CiPRICS) : A study protocol for a double-blind, randomised, placebo-controlled, proof-of-concept study
- Shrunken Pore Syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting.
- Efficacy and safety of the Lotus Valve System for treatment of patients with severe aortic valve stenosis and intermediate surgical risk : Results from the Nordic Lotus-TAVR registry